Skip to main content

Table 1 Details of graft, cell dosing, and graft assessment plan

From: iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants

Donor Recipient Treatment Group purpose Assessments (d)
C57BL/6 C57BL/6 Saline Saline-treated syngeneic control 8–14, 20, 28, 90
BALB/c C57BL/6 Saline Saline-treated allogeneic control 8–14, 20, 28, 90
BALB/c C57BL/6 iPSC-derived MSCs To test the efficacy of iPSC-derived MSCs 8–14, 20, 28, 90
  1. Sample size (n) = 12–18 transplants/time points/experiment